Angioblast(美国)

Angioblast Systems

美国AngioblastSystemswww.angioblast.comAngioblastSystems,Inc.(“Angioblast”orthe“Company”)isaprivatelyheldbiotechnologycompanyformedin2001.TheCompanyiscommittedtobecomingaworldlea derinthedevelopmentandcommercializationofnoveltherapeuticproductsforthetreatmentofcardiovasculardiseases(“CVD”)andvasculardisorders.AngioblastintendstoachievethisgoalthroughtheadvancementofitsthreeleadandgroundbreakingproductcandidatesthathaveeachbeenproventobeeffectiveinanimalmodelsofhumanCVD:specialadultstemcellscalledMesenchymalPrecursorCells(“MPC”)peptide-basedtherapeuticsthatinducestemcellmigration,angiogenesis,andcardiovascularrecovery,theleadcandidatebeingstromal-derivedfactor1(“SDF-1”)productsdeliveredindrug-elutingstentsforcoronaryandperipheralarterydisease,consistingofRNAsilencingtech